PT2700412T - Probióticos, iga secretora e inflamação - Google Patents
Probióticos, iga secretora e inflamaçãoInfo
- Publication number
- PT2700412T PT2700412T PT131894016T PT13189401T PT2700412T PT 2700412 T PT2700412 T PT 2700412T PT 131894016 T PT131894016 T PT 131894016T PT 13189401 T PT13189401 T PT 13189401T PT 2700412 T PT2700412 T PT 2700412T
- Authority
- PT
- Portugal
- Prior art keywords
- probiotics
- inflammation
- secretory iga
- secretory
- iga
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08158827A EP2138186A1 (en) | 2008-06-24 | 2008-06-24 | Probiotics, secretory IgA and inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2700412T true PT2700412T (pt) | 2017-11-09 |
Family
ID=39855103
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97691505T PT2318046E (pt) | 2008-06-24 | 2009-06-16 | Probióticos, iga secretora e inflamação |
PT131894016T PT2700412T (pt) | 2008-06-24 | 2009-06-16 | Probióticos, iga secretora e inflamação |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97691505T PT2318046E (pt) | 2008-06-24 | 2009-06-16 | Probióticos, iga secretora e inflamação |
Country Status (11)
Country | Link |
---|---|
US (2) | US9822167B2 (pt) |
EP (3) | EP2138186A1 (pt) |
JP (1) | JP2011525483A (pt) |
CN (1) | CN102076360B (pt) |
AU (1) | AU2009264417B2 (pt) |
BR (1) | BRPI0914561A2 (pt) |
CA (1) | CA2727300A1 (pt) |
ES (2) | ES2447572T3 (pt) |
PL (1) | PL2318046T3 (pt) |
PT (2) | PT2318046E (pt) |
WO (1) | WO2009156301A1 (pt) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2138187A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
EP2138186A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
EP2731458A1 (en) * | 2011-07-12 | 2014-05-21 | Nestec S.A. | Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CN102618461B (zh) * | 2012-03-09 | 2014-04-09 | 北京和美科盛生物技术有限公司 | 一株可以促进肠道中SIgA分泌的益生菌及其检测方法 |
US10010564B2 (en) * | 2012-09-11 | 2018-07-03 | Khaled Mahmood Al-Qaoud | Camel milk-based topical pharmaceutical composition |
US10278404B2 (en) * | 2012-09-11 | 2019-05-07 | Al-Urdonia Lemudaddat Al-Ajsam Co | Immunized camel milk-based composition for the treatment or prevention of gastrointestinal infections |
FR2999932B1 (fr) * | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
FR2999933B1 (fr) | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
US9458230B2 (en) | 2013-01-04 | 2016-10-04 | Wisconsin Alumni Research Foundation | Secretory IGA compositions, methods of making and methods of use thereof |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US9468674B2 (en) | 2013-09-24 | 2016-10-18 | Wisconsin Alumni Research Foundation | Methods of use of secretory IgA |
MX2017008449A (es) | 2014-12-23 | 2017-10-12 | 4D Pharma Res Ltd | Polipeptido de pirina y modulacion inmune. |
CN113862175A (zh) | 2014-12-23 | 2021-12-31 | 4D制药研究有限公司 | 免疫调控 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CN114984057A (zh) | 2015-06-15 | 2022-09-02 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CA2988695A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
PT3209310T (pt) | 2015-11-20 | 2018-04-20 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
EP3397075A1 (en) * | 2015-12-29 | 2018-11-07 | N.V. Nutricia | Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria |
WO2017114900A1 (en) | 2015-12-29 | 2017-07-06 | N.V. Nutricia | Fermented formula with non-digestible oligosaccharides |
CA3016179C (en) | 2016-03-04 | 2019-08-13 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
WO2017223419A1 (en) * | 2016-06-24 | 2017-12-28 | Ig Biosciences Corporation | Prebiotic neutraceutical compositions and methods of treatment using the same |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
PL3630136T3 (pl) | 2017-05-22 | 2021-09-13 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
DK3600364T3 (da) | 2017-06-14 | 2020-08-31 | 4D Pharma Res Ltd | Sammensætninger omfattende en bakteriestamme af slægten megasphaera og anvendelser deraf |
CN109744441A (zh) * | 2017-11-02 | 2019-05-14 | 健茂生物科技股份有限公司 | 具抗氧化功能的仙人掌果与红龙果复合发酵饮品的制备工艺 |
JP7296454B2 (ja) * | 2018-10-02 | 2023-06-22 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 炎症関連胃腸障害の処置のためのプロバイオティクスの組み合わせ |
WO2020123121A1 (en) * | 2018-12-11 | 2020-06-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of screening antibodies for treating and/or preventing necrotizing enterocolitis (nec) |
BR112021010049A2 (pt) * | 2018-12-21 | 2021-08-17 | Société des Produits Nestlé S.A. | combinação de probióticos para tratamento de distúrbios alérgicos |
TW202103583A (zh) * | 2019-03-29 | 2021-02-01 | 日商養樂多本社股份有限公司 | 源自飲食之高多醣利用性之新穎雙叉桿菌屬細菌 |
US20220296706A1 (en) * | 2019-06-28 | 2022-09-22 | Societe Des Produits Nestle S.A. | COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS |
IL297289A (en) | 2020-04-27 | 2022-12-01 | Nestle Sa | A method for making products like milk |
US20230159976A1 (en) | 2020-04-27 | 2023-05-25 | Societe Des Produits Nestle S.A. | Method for producing milk like products |
CA3235973A1 (en) | 2021-10-27 | 2023-05-04 | Societe Des Produits Nestle S.A. | Method for producing milk like products |
AU2022378534A1 (en) | 2021-10-27 | 2024-04-18 | Société des Produits Nestlé S.A. | Method for producing milk like products |
AU2022378939A1 (en) | 2021-10-27 | 2024-04-11 | Société des Produits Nestlé S.A. | Method for producing milk like products |
CA3234240A1 (en) | 2021-10-27 | 2023-05-04 | Maria MARQUES DE LIMA | Method for producing milk like products |
CA3234085A1 (en) | 2021-10-27 | 2023-05-04 | Maria MARQUES DE LIMA | Method for producing milk like products |
WO2023118197A1 (en) | 2021-12-20 | 2023-06-29 | Société des Produits Nestlé S.A. | Secretory iga-biotic complexes and uses thereof |
CN114990004B (zh) * | 2022-04-19 | 2023-09-15 | 尚品健康科技(青岛)有限公司 | 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用 |
KR102590051B1 (ko) * | 2022-10-20 | 2023-10-16 | 주식회사 종근당바이오 | 건강한 한국인의 장내 핵심 유산균을 이용한 장내 마이크로바이옴 환경 및 장 건강 개선용 프로바이오틱스 조성물 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5589233A (en) | 1978-12-28 | 1980-07-05 | Shogo Nakano | Preparation of additive for breeding of new born cattle |
JP2968374B2 (ja) | 1991-05-16 | 1999-10-25 | 株式会社ヤクルト本社 | IgA産生促進剤 |
JPH06234647A (ja) | 1993-02-12 | 1994-08-23 | Yakult Honsha Co Ltd | IgA産生促進剤およびその製造法 |
JP3269890B2 (ja) | 1993-08-25 | 2002-04-02 | 株式会社ヤクルト本社 | ワクチンの効果増強剤及び効果増強食品 |
US5531988A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Bacteria and immunoglobulin-containing composition for human gastrointestinal health |
AUPN698495A0 (en) | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
WO2003041512A1 (en) * | 2001-11-12 | 2003-05-22 | Mars, Incorporated | Foodstuff |
CN100489086C (zh) * | 2003-08-21 | 2009-05-20 | 大塚制药株式会社 | 能够刺激粘膜免疫性的乳酸菌 |
AU2006215205B2 (en) * | 2005-02-02 | 2011-05-19 | Meiji Co., Ltd. | Composition for immunostimulation |
BRPI0615547A2 (pt) * | 2005-08-19 | 2011-05-24 | Unilever Nv | produto alimentìcio, preparação farmacêutica, método de fabricação de produto alimentìcio, método de fabricação de preparação farmacêutica, uso do produto alimentìcio, usos da preparação farmacêutica, método de fornecimento de benefìcios à saúde do intestino e implementos de liberação para uso com produto alimentìcio |
WO2008064489A1 (en) * | 2006-12-01 | 2008-06-05 | Mcmaster University | Probiotics to inhibit inflammation |
US20080145420A1 (en) * | 2006-12-13 | 2008-06-19 | Simon Michael R | HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
RU2010151414A (ru) * | 2008-05-15 | 2012-06-20 | В.Хэлт Л.П. (Bs) | Способ получения фракций молока, обогащенных секреторными иммуноглобулинами |
EP2127661A1 (en) * | 2008-05-27 | 2009-12-02 | Nestec S.A. | Probiotics to improve gut microbiotica |
EP2138187A1 (en) * | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
EP2138186A1 (en) * | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
-
2008
- 2008-06-24 EP EP08158827A patent/EP2138186A1/en not_active Withdrawn
-
2009
- 2009-06-16 CA CA2727300A patent/CA2727300A1/en not_active Abandoned
- 2009-06-16 ES ES09769150.5T patent/ES2447572T3/es active Active
- 2009-06-16 WO PCT/EP2009/057453 patent/WO2009156301A1/en active Application Filing
- 2009-06-16 CN CN200980124319.2A patent/CN102076360B/zh active Active
- 2009-06-16 BR BRPI0914561A patent/BRPI0914561A2/pt not_active IP Right Cessation
- 2009-06-16 AU AU2009264417A patent/AU2009264417B2/en active Active
- 2009-06-16 US US13/000,666 patent/US9822167B2/en active Active
- 2009-06-16 JP JP2011514017A patent/JP2011525483A/ja active Pending
- 2009-06-16 EP EP13189401.6A patent/EP2700412B1/en active Active
- 2009-06-16 ES ES13189401.6T patent/ES2641364T3/es active Active
- 2009-06-16 PT PT97691505T patent/PT2318046E/pt unknown
- 2009-06-16 PL PL09769150T patent/PL2318046T3/pl unknown
- 2009-06-16 EP EP09769150.5A patent/EP2318046B1/en active Active
- 2009-06-16 PT PT131894016T patent/PT2700412T/pt unknown
-
2017
- 2017-10-19 US US15/787,904 patent/US10501530B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011525483A (ja) | 2011-09-22 |
WO2009156301A1 (en) | 2009-12-30 |
AU2009264417A1 (en) | 2009-12-30 |
EP2700412A1 (en) | 2014-02-26 |
US9822167B2 (en) | 2017-11-21 |
US20180037637A1 (en) | 2018-02-08 |
CN102076360A (zh) | 2011-05-25 |
EP2318046A1 (en) | 2011-05-11 |
CN102076360B (zh) | 2018-03-09 |
US10501530B2 (en) | 2019-12-10 |
PT2318046E (pt) | 2014-02-27 |
EP2700412B1 (en) | 2017-07-26 |
US20110268743A1 (en) | 2011-11-03 |
ES2641364T3 (es) | 2017-11-08 |
ES2447572T3 (es) | 2014-03-12 |
BRPI0914561A2 (pt) | 2015-12-15 |
AU2009264417B2 (en) | 2015-04-30 |
EP2318046B1 (en) | 2013-12-04 |
EP2138186A1 (en) | 2009-12-30 |
CA2727300A1 (en) | 2009-12-30 |
PL2318046T3 (pl) | 2014-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2318046T3 (pl) | Probiotyki, wydzielnicze IGA i zapalenie | |
PL2700411T3 (pl) | Probiotyki, wydzielnicze IgA a zakażenie | |
PL3729998T3 (pl) | Złożony element zawierający dwa elementy panelowe | |
EP2127091A4 (en) | METHODS AND SYSTEMS FOR LOW DENSITY PARITY CHECK ENCODING (LDPC) | |
EP2148696A4 (en) | SURFACES, METHODS AND DEVICES USING ROLLING OF CELLS | |
EP2293135A4 (en) | MOBILE STRUCTURE AND MICROMIROIR ELEMENT USING THE SAME | |
EP2264790A4 (en) | WAVE LENGTH IMPLEMENTING MEMBER AND METHOD FOR THE PRODUCTION THEREOF | |
EP2229791A4 (en) | SYSTEM AND METHOD FOR USING WIRELESS PROGRAMMABLE CONFIDENTIAL DATA | |
IL210445A0 (en) | Split thermo - electric structure and devices and systems that utilize said structure | |
EP2259337A4 (en) | PHOTOVOLTAIC POWER DEVICE AND METHOD FOR THE PRODUCTION THEREOF | |
HK1156326A1 (en) | Anti-hepcidin-25 selective antibodies and uses thereof | |
IL213321A0 (en) | Descenting systems and methods | |
TWI365165B (en) | Elevating mechanism and ferris wheel using the same | |
EP2410584A4 (en) | THERMOELECTRIC CELL AND METHOD FOR PRODUCING THE SAME | |
GB201014198D0 (en) | Force element arrangement and method | |
TWI341628B (en) | Contact structure and bonding structure | |
EP2352100A4 (en) | DISSEMINATION DEVICE FOR SERVICE INFORMATION AND DEVICE FOR ACQUIRING SERVICE INFORMATION | |
GB0703763D0 (en) | Bone-replacement materials,methods and devices | |
GB201013552D0 (en) | Maximum entropy application methods and systems | |
EP2123376A4 (en) | STOP STRUCTURE AND MANUFACTURING METHOD THEREFOR | |
GB0719048D0 (en) | Endocrine disruption | |
TWI367195B (en) | Torque limiting roller and medium separating mechanism using the same | |
TWI370824B (en) | The phpit and fabrication thereof | |
IL205987A0 (en) | Bank1 splice variant, its preparation and use | |
GB0812277D0 (en) | Antibody and uses thereof |